Insights on the Aptamers: Therapeutics, Technologies and Services Global Market to 2035
April 13, 2022 07:33 ET
|
Research and Markets
Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Aptamers: Therapeutics, Technologies and Services Market" report has been added to ResearchAndMarkets.com's offering. This report features an...
Epigenetics Global and Regional Market Analysis: A $14,311.1 Million Market by 2031, Growing at a CAGR of 17% During 2021-2031
February 21, 2022 04:08 ET
|
Research and Markets
Dublin, Feb. 21, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Market - A Global and Regional Analysis: Focus on Product, Mechanism, Technology, Application, End User, and Region - Analysis and...
Insights on the Cell-Free DNA Isolation and Extraction Global Market to 2031 - Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets Presents Opportunities
February 11, 2022 07:43 ET
|
Research and Markets
Dublin, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The "Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis: Focus on Consumables, Platform, Techniques, Application, End User, and...
Global Pharmacogenomics Services Market (2021 to 2031) - Focus on Service, Technology, Application, End-user and Country-Wise Analysis
January 24, 2022 04:13 ET
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Services Market - A Global and Regional Analysis: Focus on Service, Technology, Application, End User, and Country-Wise Analysis -...
Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
January 11, 2022 06:30 ET
|
Progenity, Inc.
SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22
January 05, 2022 06:30 ET
|
Progenity, Inc.
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
January 03, 2022 06:30 ET
|
Progenity, Inc.
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
December 20, 2021 16:05 ET
|
Progenity, Inc.
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
Global Targeted Therapeutics Market Research Report 2021: Market will Surpass $100+ Billion in 2021 - Forecast to 2026
December 15, 2021 09:03 ET
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Targeted Therapeutics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for targeted...
Global Acute Lymphoblastic Leukemia Treatment Market Report 2021-2026: Opportunities with Limited Players in the Market & Increasing Investment in R&D of Different Leukemia Treatments
December 14, 2021 05:48 ET
|
Research and Markets
Dublin, Dec. 14, 2021 (GLOBE NEWSWIRE) -- The "Global Acute Lymphoblastic Leukemia Treatment Market (2021-2026) by Type, Types of Cell, Therapy, Geography, Competitive Analysis and the Impact of...